IASLC Readies Release of IASLC Thoracic Oncology - 2nd Edition


Media Contact: Becky Bunn                                                                        Adam Mohrbacher   
Public Relations Manager                                                                           Digital and Social Media Manager | 720-325-2946                                       | 720-598-1943


IASLC Readies Release of IASLC Thoracic Oncology - 2nd Edition
New Edition of Signature Textbook Aims to Keep Professionals Abreast of Latest Lung Cancer Developments 

DENVER – The field of lung cancer is changing rapidly, with new discoveries, novel trials and changes in the standard of care happening at an extraordinary rate. In order to keep lung cancer physicians, physician assistants and nurses abreast of the complex, ever-evolving field of thoracic oncology, the International Association for the Study of Lung Cancer (IASLC) has produced a second edition of its signature textbook, IASLC Thoracic Oncology – 2nd Edition, in the hopes of consolidating the most reliable, up-to-date information on the subject in one comprehensive source.

The new edition of IASLC Thoracic Oncology updates large sections of the first edition of the textbook, which was released in 2014. In the interim, the science surrounding the diagnosis and treatment of lung cancer and other thoracic malignancies has exploded, with significant changes occurring in genomic phenotyping, staging, histologic classification and immunotherapeutic treatment strategies. Ultimately, new or updated material represents over 50% of the second edition of the textbook, an appropriate percentage considering the wealth of new data that has recently come to light.

“The second edition of our textbook represents the IASLC’s commitment to providing medical professionals of all disciplines with the educational tools they need to provide the highest standard of care to lung patients throughout the world,” said Fred R. Hirsch, MD, PhD, Professor of Medicine and Pathology at the University of Colorado Cancer Center and School of Medicine, and CEO of the IASLC. “Through the hard work of editors Dr. Harvey Pass, Dr. David Ball and Dr. Giorgio Scagliotti, clinicians will now have practical, relevant coverage of best practices in the epidemiology, diagnosis, treatment and advocacy of lung cancer and other thoracic diseases. We thank them and the many other global experts who contributed to this important project for their hard work.”

IASLC Thoracic Oncology – 2nd Edition will be available for pre-order at the ASCO Annual Meeting on June 2-6, 2017, in Chicago. It is also available for pre-order on Amazon and on the Elsevier Health digital bookstore. The textbook is available for purchase in both physical and digital form. Members of the IASLC are also eligible to receive a discount on the book’s cover price.

About International Association for the Study of Lung Cancer
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit for more information and follow us on Twitter @IASLC


June 2, 2017